Umbrella review: clinical VR has matured into a viable tool, with caveats clinicians should know
How this was rated
Umbrella review by recognized senior researchers in clinical VR. Evaluative rather than systematic-with-pooled-effects, so confidence is bounded by the authors editorial judgment; useful as orientation rather than as a source of pooled effect estimates.
Ratings use a simplified four-tier scheme (High, Moderate, Low, Very Low) informed by the GRADE working group. Learn more about how studies are rated.
An umbrella review by two senior figures in clinical VR examined the breadth of evidence across psychological and neurocognitive applications, concluding that VR is ready for routine clinical use in many contexts while flagging implementation challenges that practitioners should plan for.
A senior-author review providing a synthetic view of clinical VR readiness across psychological and cognitive applications; useful as a high-level orientation document, with the caveat that umbrella reviews are evaluative summaries rather than primary evidence.
Key findings
- Clinical VR has matured into a viable tool across multiple psychological and neurocognitive applications
- Anxiety disorders have the strongest current evidence base
- Implementation challenges include training, clinician acceptability, and cost-benefit calculations in routine practice
- The authors call for pragmatic trials and implementation research alongside continued efficacy work
Background
Clinical virtual reality has been an active research field since the mid-1990s, with evidence accumulating across diverse psychological and neurocognitive applications. By the mid-2010s, the question facing the field had shifted from “does it work in principle” to “is it ready for routine clinical use, and what do practitioners need to know to adopt it well.” Rizzo and Koenig - both senior researchers with long histories in clinical VR development and evaluation - addressed that question in this umbrella review.
What the researchers did
The authors conducted an umbrella review covering the major application areas of clinical VR, including anxiety disorders (specific phobias, social anxiety, PTSD), pain management, autism support, cognitive rehabilitation, and emerging applications. Rather than performing a quantitative meta-analysis, they assessed the state of evidence in each area, the maturity of clinical implementations, and the implementation challenges likely to face practitioners moving from research to routine practice.
What they found
The authors concluded that clinical VR has matured into a viable tool across multiple application areas, with anxiety disorders showing the strongest evidence base. They flagged several themes recurring across application areas: implementation challenges (clinician training, integration with routine workflows, cost-benefit considerations), the importance of pragmatic trials alongside efficacy studies, and the need for ongoing acceptability research as VR moves from specialist research settings to general clinical use. The review notes that emerging directions - including AI-driven content, automated delivery models, and condition-specific platforms - represent meaningful extensions of the foundational work but require their own evidence base.
Why this matters
This review is the kind of orientation document that newer clinicians and researchers can use to map the field. It does not provide pooled effect sizes or a primary research finding; instead, it provides a synthesis of where the field stands and what practitioners should plan for as they adopt VR. For speech-language professionals considering VR adoption, the implementation themes are particularly relevant: training and acceptability matter alongside efficacy, and routine-practice integration is a separate question from research-trial efficacy. The review also explicitly flags the need for pragmatic trials in real clinical settings, which is a useful corrective against treating efficacy-trial findings as a complete answer.
Limitations
Umbrella reviews are evaluative summaries rather than systematic-with-pooled-effects. The authors are senior figures with established positions in the field, and their judgment reflects substantive experience but is not the same as a quantitative pooled estimate. Rapidly evolving areas (AI integration, consumer-grade hardware advances) have moved on since 2017, so some of the technical context is dated even where the evaluative themes remain relevant.
Implications for practice
Clinicians considering VR adoption can draw on a maturing evidence base while planning for implementation specifics: clinician training, integration with routine practice, and cost-benefit calculations relative to existing service models. The review supports VR as an evidence-based addition to clinical practice in well-supported areas.
Implications for research
Field-wide implementation research, including health-economic analyzes, training pathway studies, and clinician-experience research, are flagged in this review as priorities. Direct trials in communication-specific contexts continue to be needed.
Where this connects to Therapy withVR
The study above is independent research and does not endorse any product. The notes below are commentary from withVR on how the themes in this research relate to features of Therapy withVR. The research findings are not claims about Therapy withVR.
Customizable Avatars
Rizzo and Koenig review highlighted that VR's clinical utility depends on configurable, condition-relevant content - Therapy withVR's customization options support that principle in practice.
AI Features
The review noted AI-driven elements as a maturing direction in clinical VR - Therapy withVR's AI features build on that direction.
Cite this study
If you reference this study in your work, the canonical citation formats are:
@article{rizzo2017,
author = {Rizzo, A. S. and Koenig, S. T.},
title = {Is clinical virtual reality ready for primetime?},
journal = {Neuropsychology},
year = {2017},
doi = {10.1037/neu0000405},
url = {https://withvr.app/evidence/studies/rizzo-koenig-2017}
}TY - JOUR
AU - Rizzo, A. S.
AU - Koenig, S. T.
TI - Is clinical virtual reality ready for primetime?
JO - Neuropsychology
PY - 2017
DO - 10.1037/neu0000405
UR - https://withvr.app/evidence/studies/rizzo-koenig-2017
ER - Know of research that should be in this hub? If a relevant peer-reviewed study is not listed here, send the reference to hello@withvr.app. The hub is kept up to date as the literature grows.
Funding & independence
Note: co-author Stacy Koenig (Koenig ST) is affiliated with Katana Simulations Pty Ltd, a commercial clinical VR company; this commercial affiliation is relevant context for evaluating the authors' conclusions. No withVR BV involvement in funding, study design, or authorship. Summary prepared independently by withVR using the published paper.